Ask AI
ProCE Banner Activity

Personalized Medicine in PBC? Filling the Guideline Gap

Clinical Thought

We are at an interesting crossroads with managing PBC, as new treatments have recently been approved as second-line agents, but the guidelines have not yet been updated.

Released: November 04, 2025

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.

Disclosure

Primary Author

Alan Bonder, MD, AGAF: consultant/advisor/speaker: Chemomab, Gilead, Intercept, Ipsen; researcher: Chemomab, Gilead, Intercept, Ipsen.